Sumeet Bagadia, Executive Director at Choice Broking, believes the Indian stock market bias has improved after the pullback ...

As the rising star of cell therapy biotechs, Iovance Biotherapeutics ( IOVA 3.76%) is a hot stock that's capturing a lot of ...

The stock market has been on a tear for the last two years. The benchmark S&P 500 (SNPINDEX: ^GSPC) index is up 24% this year and nearly 50% over the last two years (as of Nov. 20). Given this ...